A9568 Technetium tc99m arcitumomab

Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 0 units per day (practitioner), rationale: Drug discontinued